Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2019 Filed Feb 22, 2019 21:36 UTC |
King SashaChief Commercial Officer
|
SaleCommon Stock | 7,500 | $29.03 | $217,725.00 |
DisclosureSEC source: 0000899243-19-004606 · doc4.xml · nonDerivative · entry 2 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,887 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.06, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 22, 2019 Filed Feb 22, 2019 21:36 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 7,500 | $5.90 | $44,250.00 |
DisclosureSEC source: 0000899243-19-004606 · doc4.xml · nonDerivative · entry 1 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 937 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · derivative · entry 7 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,138 Underlying: Common Stock · 937 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 833 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · derivative · entry 6 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,167 Underlying: Common Stock · 833 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 292 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · derivative · entry 5 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,218 Underlying: Common Stock · 292 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
SaleCommon Stock | 2,200 | $26.30 | $57,860.00 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · nonDerivative · entry 4 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,060 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 937 | $5.90 | $5,528.30 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · nonDerivative · entry 3 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 833 | $1.00 | $833.00 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:35 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 292 | $6.31 | $1,842.52 |
DisclosureSEC source: 0000899243-19-004476 · doc4.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:34 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000899243-19-004151 · doc4.xml · derivative · entry 3 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 2,500 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:34 UTC |
King SashaChief Commercial Officer
|
SaleCommon Stock | 2,500 | $25.00 | $62,500.00 |
DisclosureSEC source: 0000899243-19-004151 · doc4.xml · nonDerivative · entry 2 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,887 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:34 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 2,500 | $5.90 | $14,750.00 |
DisclosureSEC source: 0000899243-19-004151 · doc4.xml · nonDerivative · entry 1 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,503 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · derivative · entry 9 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,510 Underlying: Common Stock · 3,503 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,925 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · derivative · entry 8 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,075 Underlying: Common Stock · 13,925 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,694 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · derivative · entry 7 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,306 Underlying: Common Stock · 5,694 shares Expires 2027-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/2 of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · derivative · entry 6 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 5,000 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
SaleCommon Stock | 28,122 | $25.40 | $714,298.80 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · nonDerivative · entry 5 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,198 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 3,503 | $6.31 | $22,103.93 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · nonDerivative · entry 4 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 13,925 | $5.90 | $82,157.50 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · nonDerivative · entry 3 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 5,694 | $2.80 | $15,943.20 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 00:34 UTC |
Bell Michael BrianChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.00 | $5,000.00 |
DisclosureSEC source: 0000899243-19-004150 · doc4.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:38 UTC |
Yee James PChief Medical Officer
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 3,649 | $0.00 Strike: $3.97 | $0.00 |
DisclosureSEC source: 0000899243-19-003537 · doc4.xml · derivative · entry 5 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,649 shares Expires 2020-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:38 UTC |
Yee James PChief Medical Officer
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 3,649 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0000899243-19-003537 · doc4.xml · derivative · entry 4 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,649 shares Expires 2020-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:38 UTC |
Yee James PChief Medical Officer
|
SaleCommon Stock | 32,500 | $23.88 | $776,100.00 |
DisclosureSEC source: 0000899243-19-003537 · doc4.xml · nonDerivative · entry 3 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,692 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $24.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:38 UTC |
Yee James PChief Medical Officer
|
Exercise / conversionCommon Stock | 3,649 | $3.97 | $14,497.48 |
DisclosureSEC source: 0000899243-19-003537 · doc4.xml · nonDerivative · entry 2 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2018. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:38 UTC |
Yee James PChief Medical Officer
|
Exercise / conversionCommon Stock | 3,649 | $3.70 | $13,497.65 |
DisclosureSEC source: 0000899243-19-003537 · doc4.xml · nonDerivative · entry 1 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2018. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:55 UTC |
King SashaChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0000899243-19-002744 · doc4.xml · derivative · entry 4 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2029-02-04 F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 4, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:55 UTC |
King SashaChief Commercial Officer
|
Tax withholdingCommon Stock | 3,045 | $27.17 | $82,732.65 |
DisclosureSEC source: 0000899243-19-002744 · doc4.xml · nonDerivative · entry 3 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,887 F3 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the immediate vesting of restricted stock units. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:55 UTC |
King SashaChief Commercial Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002744 · doc4.xml · nonDerivative · entry 2 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,932 F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:55 UTC |
King SashaChief Commercial Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002744 · doc4.xml · nonDerivative · entry 1 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,932 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 4, 2019 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:58 UTC |
Seeto ReginaldSee Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0000899243-19-002749 · doc4.xml · derivative · entry 1 Seeto Reginald · CIK 0001688485 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2029-02-04 F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 4, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:56 UTC |
Yee James PChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0000899243-19-002747 · doc4.xml · derivative · entry 4 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2029-02-04 F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 4, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:56 UTC |
Yee James PChief Medical Officer
|
Tax withholdingCommon Stock | 2,766 | $27.17 | $75,152.22 |
DisclosureSEC source: 0000899243-19-002747 · doc4.xml · nonDerivative · entry 3 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,894 F3 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the immediate vesting of restricted stock units. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:56 UTC |
Yee James PChief Medical Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002747 · doc4.xml · nonDerivative · entry 2 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,660 F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:56 UTC |
Yee James PChief Medical Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002747 · doc4.xml · nonDerivative · entry 1 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,660 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 4, 2019 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:56 UTC |
Maag PeterDirector · See Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 96,000 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0000899243-19-002746 · doc4.xml · derivative · entry 6 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Stock · 96,000 shares Expires 2029-02-04 F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 4, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:56 UTC |
Maag PeterDirector · See Remarks
|
Tax withholdingCommon Stock | 1,128 | $27.17 | $30,647.76 |
DisclosureSEC source: 0000899243-19-002746 · doc4.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,717 F3 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the immediate vesting of restricted stock units. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:56 UTC |
Maag PeterDirector · See Remarks
|
GrantCommon Stock | 48,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002746 · doc4.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,845 F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:56 UTC |
Maag PeterDirector · See Remarks
|
GrantCommon Stock | 48,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002746 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,845 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 4, 2019 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:55 UTC |
Bell Michael BrianChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0000899243-19-002745 · doc4.xml · derivative · entry 4 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2029-02-04 F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 4, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:55 UTC |
Bell Michael BrianChief Financial Officer
|
Tax withholdingCommon Stock | 5,608 | $27.17 | $152,369.36 |
DisclosureSEC source: 0000899243-19-002745 · doc4.xml · nonDerivative · entry 3 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,198 F3 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the immediate vesting of restricted stock units. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:55 UTC |
Bell Michael BrianChief Financial Officer
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002745 · doc4.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,806 F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 02:55 UTC |
Bell Michael BrianChief Financial Officer
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002745 · doc4.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,806 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 4, 2019 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| January 28, 2019 Filed Jan 29, 2019 20:47 UTC |
Yee James PChief Medical Officer
|
Tax withholdingCommon Stock | 845 | $27.46 | $23,203.70 |
DisclosureSEC source: 0000899243-19-002147 · doc4.xml · nonDerivative · entry 1 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,660 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 01:48 UTC |
Maag PeterDirector · See Remarks
|
Tax withholdingCommon Stock | 1,556 | $27.46 | $42,727.76 |
DisclosureSEC source: 0000899243-19-002148 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,845 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| January 22, 2019 Filed Jan 23, 2019 21:42 UTC |
Yee James PChief Medical Officer
|
Tax withholdingCommon Stock | 2,139 | $25.05 | $53,581.95 |
DisclosureSEC source: 0000899243-19-001827 · doc4.xml · nonDerivative · entry 1 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,505 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 02:44 UTC |
Abernethy AmyDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.88 | $0.00 |
DisclosureSEC source: 0000899243-19-001830 · doc4.xml · derivative · entry 2 Abernethy Amy · CIK 0001590728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 5,000 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/36th of the shares subject to the option vested on August 2, 2018 and 1/36th of the shares subject to the option vested or vest monthly thereafter. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 02:44 UTC |
Abernethy AmyDirector
|
Exercise / conversionCommon Stock | 5,000 | $12.88 | $64,400.00 |
DisclosureSEC source: 0000899243-19-001830 · doc4.xml · nonDerivative · entry 1 Abernethy Amy · CIK 0001590728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 02:48 UTC |
Bell Michael BrianChief Financial Officer
|
Tax withholdingCommon Stock | 1,432 | $25.05 | $35,871.60 |
DisclosureSEC source: 0000899243-19-001833 · doc4.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,806 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 02:43 UTC |
Maag PeterDirector · See Remarks
|
Tax withholdingCommon Stock | 8,140 | $25.05 | $203,907.00 |
DisclosureSEC source: 0000899243-19-001829 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,401 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.